Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature.
Baranyai T, Giricz Z, Varga ZV, Koncsos G, Lukovic D, Makkos A, Sárközy M, Pávó N, Jakab A, Czimbalmos C, Vágó H, Ruzsa Z, Tóth L, Garamvölgyi R, Merkely B, Schulz R, Gyöngyösi M, Ferdinandy P. Baranyai T, et al. Among authors: makkos a. J Transl Med. 2017 Apr 1;15(1):67. doi: 10.1186/s12967-017-1166-z. J Transl Med. 2017. PMID: 28364777 Free PMC article.
Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion.
Brenner GB, Makkos A, Nagy CT, Onódi Z, Sayour NV, Gergely TG, Kiss B, Görbe A, Sághy É, Zádori ZS, Lázár B, Baranyai T, Varga RS, Husti Z, Varró A, Tóthfalusi L, Schulz R, Baczkó I, Giricz Z, Ferdinandy P. Brenner GB, et al. Among authors: makkos a. Cells. 2020 Feb 26;9(3):551. doi: 10.3390/cells9030551. Cells. 2020. PMID: 32111102 Free PMC article.
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats.
László SB, Lázár B, Brenner GB, Makkos A, Balogh M, Al-Khrasani M, Hutka B, Mohammadzadeh A, Kemény Á, László T, Scheich B, Szabados T, Kenyeres É, Giricz Z, Bencsik P, Varga ZV, Novák J, Helyes Z, Ferdinandy P, Gyires K, Zádori ZS. László SB, et al. Among authors: makkos a. Biochem Pharmacol. 2020 Aug;178:114099. doi: 10.1016/j.bcp.2020.114099. Epub 2020 Jun 12. Biochem Pharmacol. 2020. PMID: 32540483 Free article.
AIM2-driven inflammasome activation in heart failure.
Onódi Z, Ruppert M, Kucsera D, Sayour AA, Tóth VE, Koncsos G, Novák J, Brenner GB, Makkos A, Baranyai T, Giricz Z, Görbe A, Leszek P, Gyöngyösi M, Horváth IG, Schulz R, Merkely B, Ferdinandy P, Radovits T, Varga ZV. Onódi Z, et al. Among authors: makkos a. Cardiovasc Res. 2021 Nov 22;117(13):2639-2651. doi: 10.1093/cvr/cvab202. Cardiovasc Res. 2021. PMID: 34117866
Rosiglitazone Does Not Show Major Hidden Cardiotoxicity in Models of Ischemia/Reperfusion but Abolishes Ischemic Preconditioning-Induced Antiarrhythmic Effects in Rats In Vivo.
Weber BY, Brenner GB, Kiss B, Gergely TG, Sayour NV, Tian H, Makkos A, Görbe A, Ferdinandy P, Giricz Z. Weber BY, et al. Among authors: makkos a. Pharmaceuticals (Basel). 2022 Aug 26;15(9):1055. doi: 10.3390/ph15091055. Pharmaceuticals (Basel). 2022. PMID: 36145276 Free PMC article.
38 results